[Elsevier] Structure prediction and opportunity-cost scheduler for LLM inference |
|
This post will be closed automatically in 2026-08-06 07:51
Reward10points
|
10
PTPN2: Advances and perspectives in cancer treatment potential and inhibitor research
10
Towards understanding enhanced hypoglycemic activity of fermented bee pollen in insulin-resistant HepG2 cells by widely targeted metabolomics analysis
10
Enhanced activity for producing CO2-based polyols enabled by Zn-Co DMC/c-CTA catalytic system
10
Evaluating the polypharmacological potency of FEDPN from ChEMBL BioAssays against lung cancer EGFR, ALK, TrkA and KRAS proteins
20
Targeting TDP-43 in ALS: Regulatory hurdles, trial design deficiencies, and the causal evidence gap for CTx1000
